tldrdaily.news logo
Tag

Jn1variant

All articles tagged with #jn1variant

health2 years ago

"Understanding the JN.1 Variant Surge: Hospitalizations Rise Amid New COVID Wave"

The United States is witnessing a surge in COVID-19 cases, with a new variant, JN.1, becoming the dominant strain and accounting for over 60% of new infections. Hospitalizations have increased for the eighth consecutive week post-holidays. Epidemiologist Jessica Malaty Rivera discusses the current situation and its implications for future COVID management. Experts are urging the public to exercise caution in response to the rising numbers.

via PBS NewsHour|
##covid19#epidemiology
health2 years ago

"JN.1 Variant Dominates with High Transmissibility and Notable Symptoms, Raising Global Alert"

The CDC reports that the COVID-19 subvariant JN.1, an offspring of BA.2.86, now constitutes approximately 62% of cases in the U.S. as of January 5. This variant is also prevalent in Europe and increasing in Asia. Despite a rise in COVID-19 hospitalizations, there is no current evidence that JN.1 leads to more severe disease, and existing vaccines are expected to provide increased protection against it. The World Health Organization has labeled JN.1 as a "variant of interest" with a low public health risk.

via Reuters|
##cdc#covid19
health2 years ago

"Rising JN.1 Variant Dominance and Detection Efficacy Raise Alarm Nationwide"

Marin County health officials report the spread of a new COVID-19 omicron variant, JN.1, which is estimated to account for 20% of cases in the county and up to 50% of U.S. cases. The variant is more transmissible but not linked to more severe illness. Despite the availability of a vaccine effective against JN.1, only half of Marin's most vulnerable population has been vaccinated. As schools reopen after the holiday break, officials emphasize adherence to COVID-19 protocols, including testing and mask-wearing for symptomatic individuals.

via Marin Independent Journal|
##covid19#health
health2 years ago

"Understanding the JN.1 Variant: The New Face of COVID's Winter Resurgence in the U.S."

The new JN.1 coronavirus variant has become the dominant strain in the U.S., accounting for 62% of cases, and is more transmissible than previous strains. Despite a significant rise in COVID-19 cases this winter, hospitalizations have not increased at the same rate and are approximately 30% lower than the same period last year. The updated COVID-19 vaccines are showing strong protection against severe disease from JN.1, with a preprint study indicating a significant boost in antibody protection. However, vaccination rates for the updated shots remain low in the U.S. Health experts emphasize the importance of vaccination, especially for vulnerable populations, as the winter COVID wave is expected to peak soon.

via NBC News|
##covid19#health
health2 years ago

"Effectiveness of COVID Tests Against Rising JN.1 Variant in the U.S."

The U.S. is experiencing a resurgence of COVID-19 infections with the new JN.1 variant becoming the dominant strain, accounting for about 44% of cases by mid-December. Despite rising hospitalizations and deaths, the severity of the surge is mitigated by mild infections and sufficient hospital capacity. However, vaccination rates remain low, with only 19% of adults having received the latest shot, raising concerns for vulnerable populations. The CDC continues to monitor the situation, emphasizing the virus as a serious public health threat, particularly in nursing homes where vaccination rates are even lower. Seasonal factors and the transmissibility of the JN.1 variant are contributing to the increased spread, while reduced testing and isolation practices due to cost and policy changes may be exacerbating the situation.

via Yahoo! Voices|
##cdc#covid19
health2 years ago

"JN.1 Variant Surge: The New Face of COVID in the U.S."

The U.S. is experiencing a resurgence of COVID-19 infections with the new JN.1 variant now dominant, accounting for about 44% of cases. Despite a rise in hospitalizations and deaths, the severity of the surge is mitigated by mild infections and sufficient hospital capacity. However, vaccination rates remain low, with only 19% of adults having received the latest shot, and the CDC continues to monitor the situation through wastewater analysis, which shows high levels of viral activity, particularly in the Midwest. The Biden administration is addressing low vaccination rates in nursing homes and the public, while experts express concern over the public's reduced testing and isolation practices.

via The Hill|
##cdc#covid19
health2 years ago

"Resurgence of Mask Mandates in Hospitals Amid Rising Flu and COVID-19 Cases"

As respiratory illnesses, including Covid, the flu, and RSV, surge in the U.S., mask mandates are being reinstated in healthcare settings across several states such as Illinois, Massachusetts, New York, and California. The rise in hospitalizations has been linked to the "tripledemic" and the spread of the new Covid variant JN.1, which has become a variant of interest due to its rapid growth and potential risk to global public health. Despite concerns, vaccine makers have assured that current shots offer some protection against this variant.

via Forbes|
##covid19#health
health2 years ago

"JN.1 Variant Surge: The New Face of COVID in the U.S. and Beyond"

The U.S. is experiencing another COVID-19 surge with the JN.1 variant now dominant, leading to increased mask mandates in health facilities and concerns about post-holiday transmission. Despite a rise in cases, hospitalizations and deaths are lower compared to the previous year. The CDC continues to recommend isolation and vaccination, but adherence and update on vaccines remain low. Public health officials are combating skepticism and misinformation about vaccines, while also managing the impact of other respiratory viruses like flu and RSV. Wastewater data indicates high virus levels, but the situation in hospitals is not as severe as last year, with COVID-19 being a major cause of respiratory illness but flu cases also rising.

via The Washington Post|
##covid19#health
health2 years ago

"JN.1 Variant Emerges with Unique Symptoms, Now 30% of US COVID Cases"

The latest Covid-19 sub-variant JN.1 has been associated with new symptoms such as anxiety and trouble sleeping, in addition to the more common respiratory symptoms. Data from the UK's Office for National Statistics indicates a shift in symptom patterns, with loss of taste and smell now being less common. The JN.1 variant, a descendant of Omicron, is more transmissible due to a specific mutation and has spread to over 40 countries. Health authorities recommend continued preventive measures like mask-wearing and hand washing to curb the spread.

via India Today|
##covid19#health
health2 years ago

"Understanding the Persistent Risks and Impacts of Long COVID in the Pandemic Era"

The World Health Organization's infectious disease expert, Dr. Marian Van Kerkhove, warns that COVID-19 remains a global health threat and pandemic, with the JN.1 variant now the most prevalent strain. Despite the availability of tools to prevent infections, hospitalizations, deaths, and long COVID, there has been a 10% increase in virus-related deaths and over 250,000 new infections globally in the week leading up to Christmas Eve, with Russia reporting nearly 100,000 cases. Dr. Van Kerkhove urges against complacency from both governments and individuals, emphasizing the ongoing traumatic impact of the pandemic.

via The Messenger|
##covid19#health
health2 years ago

"JN.1 Variant Rises to Dominate U.S. COVID Cases with Unique Symptoms"

The CDC reports that the new COVID-19 variant JN.1 accounts for 15% to 29% of current U.S. cases and is growing rapidly, though it doesn't seem to cause more severe illness and existing vaccines remain effective against it. The variant's rise is part of a pattern of COVID-19 increases observed around the new year, and while it's more transmissible or immune-evasive, public health risk isn't considered higher than with other variants. Health outcomes are more dependent on individual health and immunity levels. The CDC will continue to monitor the spread of JN.1.

via Fox News|
##cdc#covid19
health2 years ago

"JN.1 Variant Emerges with Unique Symptoms, Now 30% of US COVID Cases"

A new Covid strain, JN.1, has become prevalent globally, introducing two new symptoms: trouble sleeping and anxiety, in addition to the common Covid symptoms. The strain is a derivative of BA.2.86 and may be more transmissible. Health authorities, noting an increase in SARS-CoV-2 prevalence, are urging people to get vaccinated with the updated vaccine, which is believed to offer protection against severe disease from this variant. The UK Health Security Agency is particularly encouraging vaccinations ahead of the winter season to prevent serious illness and ensure people can enjoy festive celebrations.

via Daily Record|
##covid19#health
health2 years ago

"Rising JN.1 Variant: Surging Cases, New Symptoms, and Its Impact in the US and Israel"

Health officials are raising concerns about the new COVID-19 variant JN.1, which is spreading rapidly worldwide and has been linked to two new symptoms: trouble sleeping and heightened anxiety. The variant is less associated with loss of taste and smell, and experts are emphasizing the importance of updated vaccines to protect against severe disease. Campaigns are underway to encourage vaccination against both flu and COVID-19, especially as the winter season progresses.

via Express|
##covid19#health
health2 years ago

"Understanding JN.1: The New Dominant COVID Variant and Its Unique Impact"

The JN.1 variant, a sub-variant of Omicron, is causing many individuals, referred to as 'novids,' to contract COVID-19 for the first time. It is more transmissible than previous strains but does not appear to cause more severe disease. Symptoms are similar to other COVID-19 variants, with upper respiratory issues being common. Vaccination remains the best defense, and new vaccines should be effective against JN.1. There is also concern that COVID-19, particularly the JN.1 variant, could lead to increased heart issues, as the virus affects ACE2 receptors which are abundant in the heart. Health guidelines suggest staying at home and avoiding contact with others if tested positive, with the duration varying by age and vulnerability of contacts.

via Express|
##covid19#health
health2 years ago

"Rise of JN.1: The New Dominant and Highly Transmissible COVID Variant in the U.S."

The Covid JN.1 variant, a sub-variant of Omicron, has been reported in India with over 150 cases. It is more transmissible than previous strains but does not appear to cause more severe disease. Common symptoms include fever, cough, cold, headache, and gastrointestinal issues. Health experts recommend the reinstatement of social distancing and other preventive measures, especially during the New Year celebrations and cold weather, which could increase the risk of spread. Vaccines may offer some protection against JN.1, and there is no evidence of increased severity or fatality rates compared to other variants. People with co-morbidities or lung damage from previous Covid waves should exercise caution.

via Hindustan Times|
##covid19#health